Chemokine-like factor 1 is a functional ligand for CC chemokine receptor 4 (CCR4)

被引：62
|
作者：
Wang, Y
Zhang, YM
Yang, X
Han, WL
Liu, YN
Xu, QM
Zhao, R
Di, CH
Song, QS
Ma, DL [1 ]
机构：
[1] Peking Univ, Ctr Human Dis Genom, Beijing 100083, Peoples R China
[2] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Lab Med Immunol, Beijing 100083, Peoples R China
来源：
LIFE SCIENCES | 2006年 / 78卷 / 06期
关键词：
chemokine; CLF; recombinant CKLF1; TARC/CCL17; CCR4; ligand;
D O I：
10.1016/j.lfs.2005.05.070
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Chemokine-like factor 1 (CKLF1) exhibits chemotactic effects on leukocytes. Its amino acid sequence shares similarity with those of TARC/CCL17 and MDC/CCL22, the cognate ligands for CCR4. The chemotactic effects of CKLF1 for CCR4-transfected cells could be desensitized by TARC/CCL17 and markedly inhibited by PTX. CKLF1 induced a calcium flux in CCR4-transfected cells and fully desensitized a subsequent response to TARC/CCL17, and TARC/CCL17 could partly desensitize the response to CKLF1. CKLF1 caused significant receptor internalization in pCCR4-EGFP transfected cells. Taken together, CKLF1 is a novel functional ligand for CCR4. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码：614 / 621
页数：8
相关论文
共 50 条
  • [31] Targeting chemokine receptors in disease - a case study of CCR4
    Solari, Roberto
    Pease, James E.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 763 : 169 - 177
  • [32] The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4
    Imai, T
    Baba, M
    Nishimura, M
    Kakizaki, M
    Takagi, S
    Yoshie, O
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (23) : 15036 - 15042
  • [33] The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer
    Li, Ji-Yu
    Ou, Zhou-Luo
    Yu, San-Jian
    Gu, Xiao-Li
    Yang, Chen
    Chen, Ao-Xiang
    Di, Gen-Hong
    Shen, Zhen-Zhou
    Shao, Zhi-Ming
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 131 (03) : 837 - 848
  • [34] The expression of chemokine receptor CXCR3 and CCR4 in RA and SLE.
    Tamiya, H
    Tani, K
    Sone, S
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S256 - S257
  • [35] THE CCR4 CHEMOKINE RECEPTOR ANTAGONIST CCX6239 FOR THE TREATMENT OF ALLERGIC DISEASES
    Miao, Z.
    Wang, Y.
    Leleti, M.
    Dairaghi, D.
    Walters, M.
    Sullivan, T.
    Miao, S.
    Schall, T.
    Jaen, J.
    Powers, J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2013, 111 (05) : A108 - A109
  • [36] The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer
    Ji-Yu Li
    Zhou-Luo Ou
    San-Jian Yu
    Xiao-Li Gu
    Chen Yang
    Ao-Xiang Chen
    Gen-Hong Di
    Zhen-Zhou Shen
    Zhi-Ming Shao
    Breast Cancer Research and Treatment, 2012, 131 : 837 - 848
  • [37] The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells
    Campbell, JJ
    Haraldsen, G
    Pan, J
    Rottman, J
    Qin, S
    Ponath, P
    Andrew, DP
    Warnke, R
    Ruffing, N
    Kassam, N
    Wu, L
    Butcher, EC
    NATURE, 1999, 400 (6746) : 776 - 780
  • [38] The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells
    J. J. Campbell
    G. Haraldsen
    J. Pan
    J. Rottman
    S. Qin
    P. Ponath
    D. P. Andrew
    R. Warnke
    N. Ruffing
    N. Kassam
    L. Wu
    E. C. Butcher
    Nature, 1999, 400 : 776 - 780
  • [39] The Chemokine Receptor CCR4 is Expressed and Associated With a Poor Prognosis in Patients With Gastric Cancer
    Lee, Jun Ho
    Cho, Young-Suk
    Lee, Ji Young
    Kook, Myoung Cheorl
    Park, Jong-Whan
    Nam, Byung-Ho
    Bae, Jae-Moon
    ANNALS OF SURGERY, 2009, 249 (06) : 933 - 941
  • [40] Chemotaxis of human tonsil B lymphocytes to CC chemokine receptor (CCR) 1, CCR2 and CCR4 ligands is restricted to non-germinal center cells
    Corcione, A
    Tortolina, G
    Bonecchi, R
    Battilana, N
    Taborelli, G
    Malavasi, F
    Sozzani, S
    Ottonello, L
    Dallegri, F
    Pistoia, V
    INTERNATIONAL IMMUNOLOGY, 2002, 14 (08) : 883 - 892
12345